title: Medullary sites of action of the TRH analogue, RX 77368, for stimulation of gastric acid secretion in the rat.
abstract: Brain and spinal sites of action of the stable thyrotropin-releasing hormone (TRH) analogue, RX 77368 [pGlu-His-(3,3'-dimethyl)-Pro-NH2], for stimulation of gastric acid secretion have been investigated in urethane-anesthetized rats with gastric fistula. RX 77368 microinjected at a 7.7-pmol dose into the dorsal vagal complex or nucleus ambiguus stimulated gastric acid secretion to 62.2 +/- 15.9 and 45.3 +/- 14.3 mumol/h, respectively, whereas in the vehicle-treated group acid secretion was 0.5 +/- 1.0 mumol/h. A 10-fold higher dose of RX 77368 was inefficient when microinjected into the medial septum, central amygdala, or lateral hypothalamus. The gastric secretory response to microinjection of RX 77368 into the nucleus ambiguus was dose related (0.7-77 pmol), long-lasting (greater than 90 min), and blocked by vagotomy. TRH (144 pmol) injected into the nucleus ambiguus also stimulated gastric acid secretion but was less potent than the stable TRH analogue, whereas the unrelated peptide, oxytocin, was inactive. Intrathecal injection of RX 77368 at doses up to 2500 pmol did not modify gastric acid secretion. These results demonstrate that the dorsal vagal complex and nucleus ambiguus are TRH sites of action for stimulation of gastric acid secretion through vagal dependent pathways. These findings, added to the high concentrations of TRH-like immunoreactivity and receptors present in these nuclei, suggest a possible role of medullary TRH in the vagal regulation of gastric acid secretion.
mesh_terms: D000818:Animals; D001665:Binding Sites; D005744:Gastric Acid / Q000378:metabolism*; D007276:Injections, Intraventricular; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects / Q000502:physiology*; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D051381:Rats; D011919:Rats, Inbred Strains; D013268:Stimulation, Chemical; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000502:physiology*; D014630:Vagus Nerve / Q000187:drug effects / Q000502:physiology*
chemical_list: D013973:Thyrotropin-Releasing Hormone; C027979:L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide; D011761:Pyrrolidonecarboxylic Acid